Yuki Gosei Kogyo Co., Ltd. (TYO:4531)

Japan · Delayed Price · Currency is JPY

316.00

-16.00 (-4.82%)

Nov 6, 2026, 3:30 PM JST

Market Cap	6.81B +12.9%
Revenue (ttm)	16.37B +3.9%
Net Income	479.00M -31.1%
EPS	22.16 -31.3%
Shares Out	21.54M
PE Ratio	14.26
Forward PE	n/a
Dividend	3.00 (0.95%)
Ex-Dividend Date	Mar 30, 2027

Volume	114,000
Open	320.00
Previous Close	332.00
Day's Range	311.00 - 320.00
52-Week Range	278.00 - 640.00
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Yuki Gosei Kogyo

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets amino acids, chemical products, and pharmaceuticals in Japan and internationally. It offers food additives, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, active pharmaceutical ingredients, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1947

Employees 296

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4531

Full Company Profile

Financial Performance

In fiscal year 2026, Yuki Gosei Kogyo's revenue was 15.45 billion, an increase of 2.12% compared to the previous year's 15.13 billion. Earnings were 313.00 million, a decrease of -65.07%.

Financial Statements